Univ.-Prof. Dr. Barbara Prainsack

Professor for Comparative Policy Analysis
Deputy Head of Department
Member of the ethics committee in the fields of Social and Economic Sciences of the University of Vienna

Contact

Neues Institutsgebäude
Universitätsstr. 7/2nd floor
Room: B 208
1010 Vienna
T: +43-1-4277-494 23
F: +43-1-4277-949 4
E-Mail: barbara.prainsack@univie.ac.at
Homepages:
http://www.researchgate.net/profile/Barbara_Prainsack
http://kcl.academia.edu/BarbaraPrainsack
Social Media:
http://twitter.com/BPrainsack

Office hour

Please arrange via E-Mail

Teaching assistant: Emilia Jawad, BA

Teaching

Courses: u:find

Research interests

Health policy; practices, institutions and politics of solidarity; political, social and ethical aspects of Personalised Medicine; data-rich practices in science and medicine; regulation of DNA technologies in medicine and forensics; comparative science & technology policy

Short biography

• Study of Political Science at the University of Vienna
• 2002: Visiting Doctoral Student at the Department of Behavioral Sciences, University of California, San Francisco
• 2004: Doctoral Thesis on “’Negotiating Life’: The Regulation of Embryonic Stem Cells Research and Human Cloning in Israel“ (Dissertation Award of the Austrian Political Science Association)
• 2005-2007: Postdoctoral Student at the Department of Political Science, University of Vienna
• October 2005: Visiting Professor at the Institute of International Studies, Ramkamhaeng University, Bangkok
• Fall 2006: Guest Scientist at ESRC Centre for Economic and Social Aspects of Genomics, Cardiff University, Wales
• 2007: Senior Lecturer, then Associate Professor at the Center for Biomedicine & Society, King’s College London
• Summer semester 2010: Guest Lecturer at the Faculty of Social Sciences, Goethe University, Frankfurt
• September 2011 – Dezember 2012: Professor for Sociology and Politics of Life Sciences, Brunel University, London
• 2013-2017: Professor at the Department of Global Health & Social Medicine, King’s College London


National Ethics Councils, governmental and other advisory roles, scientific advisory board memberships

• Since 2009: Member of the Austrian Bioethics Commission
• 2009-2014: Representative of the United Kingdom in the Committee for Social Sciences, European Cooperation in Science & Technology (COST)
• Since 2011: Member of the British Royal Society of Arts
• 2011-2012: together with Aarno Palotie and Stephen Holgate: Leader of the „Forward Look“ on Personalised Medicine, European Science Foundation (ESF)
• 2015-2017: Member of the Ethics Commission of the UK National DNA Database (NDNAD), Home Office, UK
• 2016: Bellagio Fellow, Rockefeller Foundation
• Since 2017: Member, European Group on Ethics in Science and New Technologies (advising the European Commission)
• Since 2017: Elected Foreign Member, Danish Royal Academy of Sciences and Letters

Selected Bibliography

A full list of publications is available here: https://www.researchgate.net/profile/Barbara_Prainsack

Books (selection)

Journal Articles (selection)

  • Barbara Prainsack. The We in the Me: Solidarity and Healthcare in the Era of Personalised Medicine. Science, Technology & Human Values (in press).
  • Barbara Prainsack. 2015. Is personalized medicine different? British Journal of Sociology 66/1: 28-35.
  • Jeantine E. Lunshof, George M. Church, and Barbara Prainsack. 2014. Raw Personal Data: Providing Access. Science 343/6169: 373-374.
  • Barbara Prainsack, and Ayo Wahlberg. 2013. Situated Bio-Regulation – Ethnographic Sensibility at the interface of STS, policy studies, and the social studies of medicine. BioSocieties 8/3: 336-359.
  • Barbara Prainsack, and Alena Buyx. 2013. A solidarity-based approach to the governance of research biobanks. Medical Law Review 21(1): 71-91.
  • Barbara Prainsack. 2011. The Power of Prediction: How Personal Genomics became a Policy Challenge. Österreichische Zeitschrift für Politikwissenschaft 40/4: 401-415.
  • Barbara Prainsack. 2011. Voting with their mice: Personal genome testing and the ‘participatory turn’ in disease research. Accountability in Research 18/3: 132-147.

Back